China NMPA Product Recall - Nucleic acid extraction reagents

This document outlines a voluntary Class II recall initiated by GeneOhm Sciences Canada, Inc., as reported by BD Medical Devices (Shanghai) Co., Ltd., to China's National Medical Products Administration (NMPA). The recall pertains to specific nucleic acid extraction reagents (Registration No.: 国械号、国械备20160212号). The primary issue prompting this action is a potential manufacturing defect involving improper sealing of the reagents. This defect could compromise the product's integrity and performance, potentially affecting diagnostic reliability. The document does not specify any inspection dates, suggesting the recall was proactively initiated by the manufacturer. Under the NMPA's regulatory framework, the required action is a Class II recall, indicating a situation where the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. The company is mandated to provide detailed information on affected product models, specifications, and batch numbers through a "Medical Device Recall Event Report Form." This ensures the removal of potentially compromised products from the market and adherence to product safety standards within China.